Skip to main content



Psychedelic Research Targets Systemic Inflammation

My latest for Project CBD is another piece on psychedelic science. Here are the first two sentences to give you a taste:  "Medical scientists have caught on to the fact that cannabinoids help fight unwanted inflammation that contributes to many diseases. But the next anti-inflammatory wonder drug could come from an even more unexpected source: psychedelics. A team at the University of New Orleans is now working to refine one of the most potent anti-inflammatory molecules known to science, a synthetic psychedelic similar to LSD called DOI (2,5-Dimethoxy-4-iodoamphetamine)." Read the full story here .

Latest Posts

Two articles in Sonoma magazine March issue

Two new stories on psychedelic science: OCD treatment with psilocybin for Project CBD & semantics of "psychedelic" vs "hallucinogen" for Pyschedelic Science Review

Airborne COVID Spread in Multifamily Housing: An overlooked risk

Essential Fatty Acids & the Endocannabinoid System

Investigating psychedelics as a treatment for dementia and early-stage Alzheimer's Disease

COVID and disposable food packaging: a harmful, unhealthy combination

The Sequestration Solution: Whendee Silver’s research shows that compost doesn’t just benefit farmers — it captures carbon

Safe to drink: Solving the arsenic problem in groundwater

Tire Leachate, Hair Relaxers, and Detergents Enter SF Bay Through Stormwater Soup

Another from the November issue of Sonoma magazine